| (EUR) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, J90.F returned -9.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +9.3% |
| 1 year | -9.0% |
| All-time high | €0.60 (Sep 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in J90.F would be worth today ›No. NurExone Biologic Inc. has not paid a dividend in the past 12 months.
NurExone Biologic Inc. is part of the Healthcare sector.
NurExone Biologic Inc. has a market cap of 30.24M EUR, based on the latest quote.
NurExone Biologic Inc. is expected to report earnings around Aug 26, 2026. That date is an estimate and has not been confirmed by the company.
